Sa.54. Interleukin-21: Intravenous Administration of Interleukin-21 Leads to Immune Activation in Humans-Preliminary Results from a Phase 1 Trial | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

HERO ID

572912

Reference Type

Journal Article

Title

Sa.54. Interleukin-21: Intravenous Administration of Interleukin-21 Leads to Immune Activation in Humans-Preliminary Results from a Phase 1 Trial

Author(s)

Lundsgaard, D; Frederiksen, K; Skrumsager, B; Davis, I; MacArthur, G; Skak, K

Year

2006

Is Peer Reviewed?

Yes

Journal

Clinical Immunology
ISSN: 1521-6616
EISSN: 1521-7035

Volume

119

Issue

Supplement 1

Page Numbers

S124-S124

DOI